ResMed, a medical device company focused on sleep apnea, has launched its first consumer product, a $149 device for tracking and improving sleep called S+. The platform includes a non-contact, ...
Two digital health companies focused on sleep published data this week that highlighted the efficacy of their respective platforms, bringing continued attention to the space after a CES week where ...
Expands ResMed’s sleep management software solution, will help sleep labs and physicians more efficiently guide patients into and through diagnosis to long-term treatment Diagnostic management ...
ResMed, a leader in digital health with over 22.5 million cloud-connected devices sold, excels in treating respiratory disorders like sleep apnea, impacting over 1 billion globally. Recent data from ...
Insights from 30,000 people across 13 countries show global sleep health awareness is growing, yet an action gap remains 53% of people surveyed ...
StockStory.org on MSN
Patient monitoring stocks Q3 recap: Benchmarking Masimo (NASDAQ:MASI)
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results